Morning Overview on MSN
A VA study of 588,000 patients ties GLP-1 drugs to a 35% higher risk of vision loss
Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...
If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 ...
CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
The blockbuster GLP-1 drugs taken by many Americans for diabetes and to aid in weight loss may also have potential for treating major depression, a new study finds. A paper published this week in ...
Medicare beneficiaries for the first time will be eligible for coverage of breakthrough GLP-1 weight-loss medications after years of struggling to get the drugs to more seniors. Starting July 1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results